Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Basolo

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1990
Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformationF Ciardiello, M L McGeady, N Kim, et al.
Journal of the National Cancer Institute|June 18, 1997
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective studyG Fontanini, M Lucchi, S Vignati, et al.
British Journal of Cancer|August 11, 2005
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancerL Boldrini, V Donati, M Dell'Omodarme, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adultsR Elisei, C Romei, T Vorontsova, et al.
Clinical Endocrinology|January 5, 2007
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patientsT Rago, G Di Coscio, F Basolo, et al.
British Journal of Cancer|January 1, 1997
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionG Fontanini, S Vignati, M Lucchi, et al.
Journal of Endocrinological Investigation|August 19, 2016
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same glandR Ciampi, C Romei, L Pieruzzi, et al.
Endocrine-Related Cancer|February 20, 2010
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patientsE Fiore, T Rago, M A Provenzale, et al.
Cytogenetics and Cell Genetics|April 25, 2000
RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISHR Cinti, L Yin, K Ilc, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology?P V Lippolis, S Tognini, G Materazzi, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1990
Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformationF Ciardiello, M L McGeady, N Kim, et al.
Journal of the National Cancer Institute|June 18, 1997
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective studyG Fontanini, M Lucchi, S Vignati, et al.
British Journal of Cancer|August 11, 2005
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancerL Boldrini, V Donati, M Dell'Omodarme, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adultsR Elisei, C Romei, T Vorontsova, et al.
Clinical Endocrinology|January 5, 2007
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patientsT Rago, G Di Coscio, F Basolo, et al.
British Journal of Cancer|January 1, 1997
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionG Fontanini, S Vignati, M Lucchi, et al.
Journal of Endocrinological Investigation|August 19, 2016
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same glandR Ciampi, C Romei, L Pieruzzi, et al.
Endocrine-Related Cancer|February 20, 2010
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patientsE Fiore, T Rago, M A Provenzale, et al.
Cytogenetics and Cell Genetics|April 25, 2000
RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISHR Cinti, L Yin, K Ilc, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology?P V Lippolis, S Tognini, G Materazzi, et al.
Pageof 17